Selected research
Industry Research
Inactivated Polio and Rabies Vaccines Industry Research Report 2026
Market perspective
The global Inactivated Polio and Rabies Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Inactivated Polio and Rabies Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Inactivated Polio and Rabies Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Inactivated Polio and Rabies Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Inactivated Polio and Rabies Vaccines include Bharat Biotech, BIO-MED, Kedrion Biopharma, Serum Institute of India, GlaxoSmithKline, Pfizer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Inactivated Polio and Rabies Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Inactivated Polio and Rabies Vaccines Market by Company
Bharat Biotech
BIO-MED
Kedrion Biopharma
Serum Institute of India
GlaxoSmithKline
Pfizer
Merck
Inactivated Polio and Rabies Vaccines Segment by Type
Inactivated Polio Vaccine
Inactivated Rabies Vaccine
Inactivated Polio and Rabies Vaccines Segment by Application
Pediatrics
Adults
Inactivated Polio and Rabies Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inactivated Polio and Rabies Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inactivated Polio and Rabies Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inactivated Polio and Rabies Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Inactivated Polio and Rabies Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Inactivated Polio and Rabies Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Inactivated Polio and Rabies Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Inactivated Polio Vaccine
- Inactivated Rabies Vaccine
Applications
- Pediatrics
- Adults
Companies covered
- Bharat Biotech
- BIO-MED
- Kedrion Biopharma
- Serum Institute of India
- GlaxoSmithKline
- Pfizer
- Merck
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Inactivated Polio and Rabies Vaccines Market Size (2021-2032)
- 2.2.2 Global Inactivated Polio and Rabies Vaccines Sales (2021-2032)
- 2.2.3 Global Inactivated Polio and Rabies Vaccines Market Average Price (2021-2032)
- 2.3 Inactivated Polio and Rabies Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Inactivated Polio Vaccine
- 2.3.3 Inactivated Rabies Vaccine
- 2.4 Inactivated Polio and Rabies Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pediatrics
- 2.4.3 Adults
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Inactivated Polio and Rabies Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Inactivated Polio and Rabies Vaccines Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Inactivated Polio and Rabies Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global Inactivated Polio and Rabies Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global Inactivated Polio and Rabies Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Inactivated Polio and Rabies Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Inactivated Polio and Rabies Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Inactivated Polio and Rabies Vaccines, Established Date
- 3.9 Global Inactivated Polio and Rabies Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bharat Biotech
- 4.1.1 Bharat Biotech Company Information
- 4.1.2 Bharat Biotech Business Overview
- 4.1.3 Bharat Biotech Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bharat Biotech Inactivated Polio and Rabies Vaccines Product Portfolio
- 4.1.5 Bharat Biotech Recent Developments
- 4.2 BIO-MED
- 4.2.1 BIO-MED Company Information
- 4.2.2 BIO-MED Business Overview
- 4.2.3 BIO-MED Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 BIO-MED Inactivated Polio and Rabies Vaccines Product Portfolio
- 4.2.5 BIO-MED Recent Developments
- 4.3 Kedrion Biopharma
- 4.3.1 Kedrion Biopharma Company Information
- 4.3.2 Kedrion Biopharma Business Overview
- 4.3.3 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product Portfolio
- 4.3.5 Kedrion Biopharma Recent Developments
- 4.4 Serum Institute of India
- 4.4.1 Serum Institute of India Company Information
- 4.4.2 Serum Institute of India Business Overview
- 4.4.3 Serum Institute of India Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Serum Institute of India Inactivated Polio and Rabies Vaccines Product Portfolio
- 4.4.5 Serum Institute of India Recent Developments
- 4.5 GlaxoSmithKline
- 4.5.1 GlaxoSmithKline Company Information
- 4.5.2 GlaxoSmithKline Business Overview
- 4.5.3 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product Portfolio
- 4.5.5 GlaxoSmithKline Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Inactivated Polio and Rabies Vaccines Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 Merck
- 4.7.1 Merck Company Information
- 4.7.2 Merck Business Overview
- 4.7.3 Merck Inactivated Polio and Rabies Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merck Inactivated Polio and Rabies Vaccines Product Portfolio
- 4.7.5 Merck Recent Developments
5 Global Inactivated Polio and Rabies Vaccines Market Scenario by Region
- 5.1 Global Inactivated Polio and Rabies Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Inactivated Polio and Rabies Vaccines Sales by Region: 2021-2032
- 5.2.1 Global Inactivated Polio and Rabies Vaccines Sales by Region: 2021-2026
- 5.2.2 Global Inactivated Polio and Rabies Vaccines Sales by Region: 2027-2032
- 5.3 Global Inactivated Polio and Rabies Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global Inactivated Polio and Rabies Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global Inactivated Polio and Rabies Vaccines Revenue by Region: 2027-2032
- 5.4 North America Inactivated Polio and Rabies Vaccines Market Facts & Figures by Country
- 5.4.1 North America Inactivated Polio and Rabies Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Inactivated Polio and Rabies Vaccines Sales by Country (2021-2032)
- 5.4.3 North America Inactivated Polio and Rabies Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Inactivated Polio and Rabies Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Inactivated Polio and Rabies Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Inactivated Polio and Rabies Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe Inactivated Polio and Rabies Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Inactivated Polio and Rabies Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Inactivated Polio and Rabies Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Inactivated Polio and Rabies Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Inactivated Polio and Rabies Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Inactivated Polio and Rabies Vaccines Market Facts & Figures by Country
- 5.7.1 South America Inactivated Polio and Rabies Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Inactivated Polio and Rabies Vaccines Sales by Country (2021-2032)
- 5.7.3 South America Inactivated Polio and Rabies Vaccines Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Inactivated Polio and Rabies Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Inactivated Polio and Rabies Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Inactivated Polio and Rabies Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Inactivated Polio and Rabies Vaccines Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Inactivated Polio and Rabies Vaccines Sales by Type (2021-2032)
- 6.1.1 Global Inactivated Polio and Rabies Vaccines Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global Inactivated Polio and Rabies Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global Inactivated Polio and Rabies Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global Inactivated Polio and Rabies Vaccines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Inactivated Polio and Rabies Vaccines Sales by Application (2021-2032)
- 7.1.1 Global Inactivated Polio and Rabies Vaccines Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2021-2032)
- 7.2 Global Inactivated Polio and Rabies Vaccines Revenue by Application (2021-2032)
- 7.2.1 Global Inactivated Polio and Rabies Vaccines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2021-2032)
- 7.3 Global Inactivated Polio and Rabies Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Inactivated Polio and Rabies Vaccines Value Chain Analysis
- 8.1.1 Inactivated Polio and Rabies Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Inactivated Polio and Rabies Vaccines Production Mode & Process
- 8.2 Inactivated Polio and Rabies Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Inactivated Polio and Rabies Vaccines Distributors
- 8.2.3 Inactivated Polio and Rabies Vaccines Customers
9 Global Inactivated Polio and Rabies Vaccines Analyzing Market Dynamics
- 9.1 Inactivated Polio and Rabies Vaccines Industry Trends
- 9.2 Inactivated Polio and Rabies Vaccines Industry Drivers
- 9.3 Inactivated Polio and Rabies Vaccines Industry Opportunities and Challenges
- 9.4 Inactivated Polio and Rabies Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst